CSMed is a healthcare practice in Antwerpen. Private Limited, started on 27 February 2024, 1 establishment.

What is the address of CSMed?

The registered office of CSMed is located at Italiëlei 10 box 102, 2000 Antwerpen.

Is CSMed still active?

Yes. According to the CBE (17 September 2026) CSMed is active, legal situation “Normale toestand”, started on 27 February 2024.

Is CSMed registered on Peppol?

Yes, CSMed is registered on the Peppol network with ID 0208:1006509117.

What is the enterprise number of CSMed?

The enterprise number of CSMed is BE1006509117.

When was CSMed founded?

CSMed was founded on 27 February 2024.

Who are the directors of CSMed?

According to the 2025 annual accounts, the directors of CSMed are: Carlo Strouven.

Is CSMed a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2024; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CSMed make in 2025?

CSMed posted a profit after taxes of € 1,133 in financial year 2025.

What is the revenue of CSMed?

As a small company, CSMed is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 10,071.

CSMed (Private Limited) - Antwerpen - BE1006509117

Dossier CSMed, printed on 17 September 2026 from databakkes.be/en/1006509117/csmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CSMed from Antwerpen, company number BE1006509117, closed financial year 2025 with a result of € 1,133 after tax. For that financial year CSMed recorded a gross margin of € 10,071 and equity of € 38,679. Compared with financial year 2024, the result moved from € 35,546 to € 1,133. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.

What it is worth Growing

€ 38,679

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,133

▼ 97% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,980

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 36,679.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 55,887

▲ € 55,025 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 36,907

€ 6,227 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 9,907

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 46,081 Gross margin 2024: € 46,081 First fiscal year in the series	€ 10,071 Gross margin 2025: € 10,071 ▼ 78% vs 2024 (€ 46,081) Unfavourable step	▼ 78%
Profit after taxes	€ 35,546 Profit after taxes 2024: € 35,546 First fiscal year in the series	€ 1,133 Profit after taxes 2025: € 1,133 ▼ 97% vs 2024 (€ 35,546) Unfavourable step	▼ 97%
Equity	€ 37,546 Equity 2024: € 37,546 First fiscal year in the series	€ 38,679 Equity 2025: € 38,679 ▲ 3% vs 2024 (€ 37,546) Favourable step	▲ 3%
Total debts	€ 18,757 Total debts 2024: € 18,757 First fiscal year in the series	€ 64,818 Total debts 2025: € 64,818 ▲ 246% vs 2024 (€ 18,757) Unfavourable step	▲ 246%
Cash	€ 38,154 Cash 2024: € 38,154 First fiscal year in the series	€ 27,980 Cash 2025: € 27,980 ▼ 27% vs 2024 (€ 38,154) Unfavourable step	▼ 27%
Retained profit	€ 35,546 Retained profit 2024: € 35,546 First fiscal year in the series	€ 36,679 Retained profit 2025: € 36,679 ▲ 3% vs 2024 (€ 35,546) Favourable step	▲ 3%
Bank debt	€ 0 Bank debt 2024: € 0 First fiscal year in the series	€ 36,907 Bank debt 2025: € 36,907 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 56,303 Balance sheet total 2024: € 56,303 First fiscal year in the series	€ 103,498 Balance sheet total 2025: € 103,498 ▲ 84% vs 2024 (€ 56,303) Unchanged	▲ 84%

Key figures of CSMed, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CSMed?

What happened at CSMed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 13, 2026 New annual accounts for financial year 2025: profit of € 1,133 (▼ 97% vs 2024). filed late Source: NBB ↗
Feb 27, 2024 New establishment in Antwerpen. KBO
2024 Carlo Strouven became a director. NBB
Feb 27, 2024 Start of the company according to the CBE. KBO

In short

From € 35,546 profit in 2024 to € 1,133 profit in 2025.

Paid € 10,935 in corporate taxes since 2024.

Best year ever: 2024, with € 35,546 profit.

Original PDFs at the National Bank ↗

A new publication or filing at CSMed? We notify you, reason included.

Follow CSMed

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Carlo Strouven

CSMed

Behind CSMed is Carlo Strouven.

See the full network in the app

Directors

According to the 2025 annual accounts

Carlo Strouven

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Italiëlei 10 box 102

2000 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

LODOS

€ 63,182 gross margin · 2022

1201 Design

H&L People

€ 2.8 million gross margin · 2025

EVELINE RERREN

€ 453 gross margin · 2025

DOKTER JULIE MORTIER

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

1006.509.117

VAT number

BE 1006.509.117

Registered office

Italiëlei 10 bus 102, 2000 Antwerpen

Names & denominations

CSMed

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 February 2024

Peppol

Active · Active since 19 May 2024

Activities · NACE

Activiteiten van verpleegkundigen en verloskundigen

Verpleegkundige activiteiten

Beroepsopleiding

View on CBE Public ↗ Annual accounts (NBB) ↗

CSMed

Financials

What happened to CSMed?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions